|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar
|
|
4
|
Ackermann CJ, Reck M, Paz-Ares L, Barlesi
F and Califano R: First-line immune checkpoint blockade for
advanced non-small-cell lung cancer: Travelling at the speed of
light. Lung Cancer. 134:245–253. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gazdar AF, Bunn PA and Minna JD:
Small-cell lung cancer: What we know, what we need to know and the
path forward. Nat Rev Cancer. 17:725–737. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li JW and Vederas JC: Drug discovery and
natural products: End of an era or an endless frontier? Science.
325:161–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs from 1981 to 2014. J Nat Prod. 79:629–661.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boufridi A and Quinn RJ: Harnessing the
properties of natural products. Annu Rev Pharmacol Toxicol.
58:451–470. 2018. View Article : Google Scholar
|
|
11
|
Harvey AL, Edrada-Ebel R and Quinn RJ: The
re-emergence of natural products for drug discovery in the genomics
era. Nat Rev Drug Discov. 14:111–129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo J, Hu YL and Wang H: Ursolic acid
inhibits breast cancer growth by inhibiting proliferation, inducing
autophagy and apoptosis, and suppressing inflammatory responses via
the PI3K/AKT and NF-κB signaling pathways in vitro. Exp Ther Med.
14:3623–3631. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Huang L, Shi H, Chen H, Tao J,
Shen R and Wang T: Ursolic acid enhances the therapeutic effects of
oxaliplatin in colorectal cancer by inhibition of drug resistance.
Cancer Sci. 109:94–102. 2018. View Article : Google Scholar :
|
|
14
|
Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF, Ye
Q, Liu CM, Shan Q and Wang YJ: Ursolic acid attenuates
D-galactose-induced inflammatory response in mouse prefrontal
cortex through inhibiting AGEs/RAGE/NF-κB pathway activation. Cereb
Cortex. 20:2540–2548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kashyap D, Sharma A, Tuli HS, Punia S and
Sharma AK: Ursolic acid and oleanolic acid: Pentacyclic Terpenoids
with promising anti-inflammatory activities. Recent Pat Inflamm
Allergy Drug Discov. 10:21–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liobikas J, Majiene D, Trumbeckaite S,
Kursvietiene L, Masteikova R, Kopustinskiene DM, Savickas A and
Bernatoniene J: Uncoupling and antioxidant effects of ursolic acid
in isolated rat heart mitochondria. J Nat Prod. 74:1640–1644. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shanmugam MK, Manu KA, Ong TH,
Ramachandran L, Surana R, Bist P, Lim LH, Kumar AP, Hui KM and
Sethi G: Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid
leads to suppression of metastasis in transgenic adenocarcinoma of
mouse prostate model. Int J Cancer. 129:1552–1563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang LJ, Tang Q, Wu J, Chen Y, Zheng F,
Dai Z and Hann SS: Inter-regulation of IGFBP1 and FOXO3a unveils
novel mechanism in ursolic acid-inhibited growth of hepatocellular
carcinoma cells. J Exp Clin Cancer Res. 35:592016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Senthil S, Chandramohan G and Pugalendi
KV: Isomers (oleanolic and ursolic acids) differ in their
protective effect against isoproterenol-induced myocardial ischemia
in rats. Int J Cardiol. 119:131–133. 2007. View Article : Google Scholar
|
|
20
|
Raphael TJ and Kuttan G: Effect of
naturally occurring triterpenoids ursolic acid and glycyrrhizic
acid on the cell-mediated immune responses of metastatic
tumor-bearing animals. Immunopharmacol Immunotoxicol. 30:243–255.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiménez-Arellanes A, Luna-Herrera J,
Cornejo-Garrido J, López-García S, Castro-Mussot ME, Meckes-Fischer
M, Mata-Espinosa D, Marquina B, Torres J and Hernández-Pando R:
Ursolic and oleanolic acids as antimicrobial and immunomodulatory
compounds for tuberculosis treatment. BMC Complement Altern Med.
13:2582013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mancha-Ramirez AM and Slaga TJ: Ursolic
acid and chronic disease: An overview of UA's effects on prevention
and treatment of obesity and cancer. Adv Exp Med Biol. 928:75–96.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kashyap D, Tuli HS and Sharma AK: Ursolic
acid (UA): A metabolite with promising therapeutic potential. Life
Sci. 146:201–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang K, Chen Y, Zhou J, Ma L, Shan Y,
Cheng X, Wang Y, Zhang Z, Ji X, Chen L, et al: Ursolic acid
promotes apoptosis and mediates transcriptional suppression of
CT45A2 gene expression in non-small-cell lung carcinoma harbouring
EGFR T790M mutations. Br J Pharmacol. 176:4609–4624. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen CJ, Shih YL, Yeh MY, Liao NC, Chung
HY, Liu KL, Lee MH, Chou PY, Hou HY, Chou JS and Chung JG: Ursolic
acid induces apoptotic cell death through AIF and Endo G release
through a mitochondria-dependent pathway in NCI-H292 human lung
cancer cells in vitro. In Vivo. 33:383–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu CG, Zhu XL, Wang W and Zhou XJ: Ursolic
acid inhibits epithelial-mesenchymal transition in vitro and in
vivo. Pharm Biol. 57:169–175. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang CY, Lin CY, Tsai CW and Yin MC:
Inhibition of cell proliferation, invasion and migration by ursolic
acid in human lung cancer cell lines. Toxicol In Vitro.
25:1274–1280. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Q, Kang J and Fu C: The independence
of and associations among apoptosis, autophagy, and necrosis.
Signal Transduct Target Ther. 3:182018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hasima N and Ozpolat B: Regulation of
autophagy by polyphenolic compounds as a potential therapeutic
strategy for cancer. Cell Death Dis. 5:e15092014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maes H, Rubio N, Garg AD and Agostinis P:
Autophagy: Shaping the tumor microenvironment and therapeutic
response. Trends Mol Med. 19:428–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen S, Zhang Y, Zhang R, Tu X and Gong X:
Ursolic acid induces autophagy in U87MG cells via ROS-dependent
endoplasmic reticulum stress. Chem Biol Interact. 218:28–41. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin CW, Chin HK, Lee SL, Chiu CF, Chung
JG, Lin ZY, Wu CY, Liu YC, Hsiao YT, Feng CH, et al: Ursolic acid
induces apoptosis and autophagy in oral cancer cells. Environ
Toxicol. 34:983–991. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang M, Zhou A, An T, Kong L, Yu C, Liu J,
Xia C, Zhou H and Li Y: N-Hydroxyphthalimide exhibits antitumor
activity by suppressing mTOR signaling pathway in BT-20 and LoVo
cells. J Exp Clin Cancer Res. 35:412016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang ZH, Chen X, Wang ZY, Chai K, Wang YF,
Xu XH, Wang XW, Lu JH, Wang YT, Chen XP and Lu JJ: Induction of
C/EBP homologous protein-mediated apoptosis and autophagy by
licochalcone A in non-small cell lung cancer cells. Sci Rep.
6:262412016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar
|
|
38
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Janku F, McConkey DJ, Hong DS and Kurzrock
R: Autophagy as a target for anticancer therapy. Nat Rev Clin
Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Luo S and Rubinsztein DC: Atg5 and Bcl-2
provide novel insights into the interplay between apoptosis and
autophagy. Cell Death Differ. 14:1247–1250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mizushima N, Yoshimori T and Ohsumi Y: The
role of Atg proteins in autophagosome formation. Annu Rev Cell Dev
Biol. 27:107–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fleming A, Noda T, Yoshimori T and
Rubinsztein DC: Chemical modulators of autophagy as biological
probes and potential therapeutics. Nat Chem Biol. 7:9–17. 2011.
View Article : Google Scholar
|
|
43
|
Shimobayashi M and Hall MN: Making new
contacts: The mTOR network in metabolism and signalling crosstalk.
Nat Rev Mol Cell Biol. 15:155–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Munson MJ and Ganley IG: MTOR, PIK3C3, and
autophagy: Signaling the beginning from the end. Autophagy.
11:2375–2376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zoncu R, Efeyan A and Sabatini DM: mTOR:
From growth signal integration to cancer, diabetes and ageing. Nat
Rev Mol Cell Biol. 12:21–35. 2011. View Article : Google Scholar
|
|
46
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Blommaart EF, Krause U, Schellens JP,
Vreeling-Sindelárová H and Meijer AJ: The phosphatidylinositol
3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in
isolated rat hepatocytes. Eur J Biochem. 243:240–246. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ge D, Han L, Huang S, Peng N, Wang P,
Jiang Z, Zhao J, Su L, Zhang S, Zhang Y, et al: Identification of a
novel MTOR activator and discovery of a competing endogenous RNA
regulating autophagy in vascular endothelial cells. Autophagy.
10:957–971. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Aoki H, Takada Y, Kondo S, Sawaya R,
Aggarwal BB and Kondo Y: Evidence that curcumin suppresses the
growth of malignant gliomas in vitro and in vivo through induction
of autophagy: Role of Akt and extracellular signal-regulated kinase
signaling pathways. Mol Pharmacol. 72:29–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cagnol S and Chambard JC: ERK and cell
death: Mechanisms of ERK-induced cell death-apoptosis, autophagy
and senescence. FEBS J. 277:2–21. 2010. View Article : Google Scholar
|
|
51
|
Wirawan E, Vanden Berghe T, Lippens S,
Agostinis P and Vandenabeele P: Autophagy: For better or for worse.
Cell Res. 22:43–61. 2012. View Article : Google Scholar :
|
|
52
|
Li Y, Xing D, Chen Q and Chen WR:
Enhancement of chemotherapeutic agent-induced apoptosis by
inhibition of NF-kappaB using ursolic acid. Int J Cancer.
127:462–473. 2010.
|
|
53
|
Shan J, Xuan Y, Zhang Q, Zhu C, Liu Z and
Zhang S: Ursolic acid synergistically enhances the therapeutic
effects of oxaliplatin in colorectal cancer. Protein Cell.
7:571–585. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Shin SW, Kim SY and Park JW: Autophagy
inhibition enhances ursolic acid-induced apoptosis in PC3 cells.
Biochim Biophys Acta. 1823:451–457. 2012. View Article : Google Scholar
|
|
55
|
Leng S, Hao Y, Du D, Xie S, Hong L, Gu H,
Zhu X, Zhang J, Fan D and Kung HF: Ursolic acid promotes cancer
cell death by inducing Atg5-dependent autophagy. Int J Cancer.
133:2781–2790. 2013.PubMed/NCBI
|
|
56
|
Zhao C, Yin S, Dong Y, Guo X, Fan L, Ye M
and Hu H: Autophagy-dependent EIF2AK3 activation compromises
ursolic acid-induced apoptosis through upregulation of MCL1 in
MCF-7 human breast cancer cells. Autophagy. 9:196–207. 2013.
View Article : Google Scholar :
|
|
57
|
Mizushima N and Yoshimori T: How to
interpret LC3 immunoblotting. Autophagy. 3:542–545. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Galluzzi L, Bravo-San Pedro JM, Levine B,
Green DR and Kroemer G: Pharmacological modulation of autophagy:
Therapeutic potential and persisting obstacles. Nat Rev Drug
Discov. 16:487–511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wiedmer T, Blank A, Pantasis S, Normand L,
Bill R, Krebs P, Tschan MP, Marinoni I and Perren A: Autophagy
inhibition improves sunitinib efficacy in pancreatic neuroendocrine
tumors via a lysosome-dependent mechanism. Mol Cancer Ther.
16:2502–2515. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang L, Qiang P, Yu J, Miao Y, Chen Z, Qu
J, Zhao Q, Chen Z, Liu Y, Yao X, et al: Identification of compound
CA-5f as a novel late-stage autophagy inhibitor with potent
anti-tumor effect against non-small cell lung cancer. Autophagy.
15:391–406. 2019. View Article : Google Scholar :
|
|
61
|
Deng S, Shanmugam MK, Kumar AP, Yap CT,
Sethi G and Bishayee A: Targeting autophagy using natural compounds
for cancer prevention and therapy. Cancer. 125:1228–1246. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Saxton RA and Sabatini DM: mTOR signaling
in growth, metabolism, and disease. Cell. 169:361–371. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wu WK, Coffelt SB, Cho CH, Wang XJ, Lee
CW, Chan FK, Yu J and Sung JJ: The autophagic paradox in cancer
therapy. Oncogene. 31:939–953. 2012. View Article : Google Scholar
|
|
64
|
Wang H, Zhang T, Sun W, Wang Z, Zuo D,
Zhou Z, Li S, Xu J, Yin F, Hua Y and Cai Z: Erianin induces
G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK
signaling pathway in human osteosarcoma cells in vitro and in vivo.
Cell Death Dis. 7:e22472016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang S, Wang K, Zhang C, Zhang W, Xu Q,
Wang Y, Zhang Y, Li Y, Zhang Y, Zhu H, et al: Overaccumulation of
p53-mediated autophagy protects against betulinic acid-induced
apoptotic cell death in colorectal cancer cells. Cell Death Dis.
8:e30872017. View Article : Google Scholar : PubMed/NCBI
|
